Basit öğe kaydını göster

Durvalumab (D) +/- tremelimumab (T) plus platinum-etoposide (EP) in 1L extensive-stage (ES) SCLC: Characteristics of long-term survivors in the CASPIAN study

dc.contributor.authorHochmair, M. J.
dc.contributor.authorReinmuth, N.
dc.contributor.authorGoldman, J. W.
dc.contributor.authorGarassino, M. C.
dc.contributor.authorChen, Y.
dc.contributor.authorHotta, K.
dc.contributor.authorPoltoratskiy, A.
dc.contributor.authorTrukhin, D.
dc.contributor.authorJi, J. H.
dc.contributor.authorÖZGÜROĞLU, MUSTAFA
dc.contributor.authorStatsenko, G.
dc.contributor.authorVoitko, O.
dc.contributor.authorConev, N. V.
dc.contributor.authorBondarenko, I.
dc.contributor.authorMann, H.
dc.contributor.authorXie, M.
dc.contributor.authorShrestha, Y.
dc.contributor.authorChugh, P.
dc.contributor.authorDalvi, T.
dc.contributor.authorPaz-Ares, L.
dc.date.accessioned2022-07-04T14:18:09Z
dc.date.available2022-07-04T14:18:09Z
dc.identifier.citationReinmuth N., Goldman J. W. , Garassino M. C. , Chen Y., Hotta K., Poltoratskiy A., Trukhin D., Hochmair M. J. , Ji J. H. , ÖZGÜROĞLU M., et al., "Durvalumab (D) +/- tremelimumab (T) plus platinum-etoposide (EP) in 1L extensive-stage (ES) SCLC: Characteristics of long-term survivors in the CASPIAN study", ANNALS OF ONCOLOGY, cilt.33, 2022
dc.identifier.issn0923-7534
dc.identifier.otherav_71cfff8b-3e6b-408e-8d83-aba24c619767
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/183268
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/71cfff8b-3e6b-408e-8d83-aba24c619767/file
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2022.02.172
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectOncology
dc.subjectHealth Sciences
dc.subjectTıp
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleDurvalumab (D) +/- tremelimumab (T) plus platinum-etoposide (EP) in 1L extensive-stage (ES) SCLC: Characteristics of long-term survivors in the CASPIAN study
dc.typeMakale
dc.relation.journalANNALS OF ONCOLOGY
dc.contributor.departmentAsklepios Lung Clin , ,
dc.identifier.volume33
dc.contributor.firstauthorID3407320


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster